A multinodular goiter is an enlarged thyroid gland that contains two or more distinct nodules, or lumps, within it. The thyroid sits at the base of your neck, and when it develops multiple nodules, it can grow large enough to become visible or press on nearby structures like your windpipe and esophagus. Most multinodular goiters don’t cause symptoms and don’t affect thyroid hormone levels, but some eventually do both.
How Multinodular Goiters Develop
Your thyroid is made up of tiny follicular cells, and not all of them behave the same way. These cells are genetically diverse, meaning some respond more aggressively to growth signals than others. When something stimulates the thyroid to grow, whether it’s low iodine intake, hormonal shifts, or other chronic low-grade triggers, certain clusters of cells expand faster and form nodules while others stay relatively quiet.
Iodine deficiency is the most well-understood cause. When the body doesn’t get enough iodine, it can’t produce adequate thyroid hormone, so the brain sends stronger signals telling the thyroid to work harder. The gland responds by growing. Once iodine levels normalize or the body’s demand for thyroid hormone drops, the thyroid enters a resting phase and stores colloid (a gel-like substance) inside its follicles. Over years, this cycle of growth and rest repeats, and the nodules that form become permanent structural changes. Each cycle can add new nodules or enlarge existing ones.
Beyond iodine, genetics play a significant role. Some people inherit thyroid cells that are more prone to forming nodules, which is why multinodular goiters often run in families. Women develop them far more frequently than men, and the likelihood increases with age.
Toxic vs. Nontoxic Goiters
Multinodular goiters fall into two categories based on whether they affect hormone production. The majority are nontoxic, meaning your thyroid hormone levels remain normal. You’re considered “euthyroid,” and the nodules are essentially structural rather than functional problems.
A toxic multinodular goiter, by contrast, produces excess thyroid hormone. This happens when one or more nodules start functioning independently, churning out hormone without responding to the brain’s normal feedback signals. The progression is typically slow and sneaky. It often begins as subclinical hyperthyroidism, where lab tests show subtle changes but you don’t feel symptoms yet. Over time, as the autonomous nodules grow larger, full-blown hyperthyroidism develops with symptoms like weight loss, rapid heartbeat, anxiety, and heat intolerance. Roughly 9 to 10 percent of people with a nontoxic multinodular goiter will develop hyperthyroidism over a span of 7 to 12 years. Less commonly, a multinodular goiter can be associated with hypothyroidism, or underactive thyroid function.
Symptoms of a Multinodular Goiter
Small multinodular goiters often cause no symptoms at all and are discovered incidentally during imaging for something else. When symptoms do appear, they’re usually caused by the physical size of the goiter pressing on surrounding structures rather than by hormone changes.
The most common compressive symptoms include:
- Difficulty breathing during exertion: found in 30 to 60 percent of patients with compressive goiters, caused by the gland narrowing the trachea
- Difficulty swallowing: pressure on the esophagus can make food feel like it’s sticking
- Choking or globus sensation: a persistent feeling of a lump or tightness in the throat
- Hoarseness or voice changes: the goiter can press on or stretch the nerve that controls your vocal cords
- Neck pressure or pain: a general sense of fullness or discomfort in the front of the neck
In rare cases, a very large goiter can create a true airway emergency. Some goiters grow downward behind the breastbone (called a substernal goiter), which can make compression harder to detect until it becomes significant.
How It’s Diagnosed
Diagnosis typically starts with a physical exam and blood work to check thyroid hormone levels and TSH (the brain’s signaling hormone to the thyroid). An ultrasound is the primary imaging tool, giving a detailed picture of how many nodules are present, their size, and their characteristics.
Not every nodule needs a biopsy. Doctors use a scoring system called TIRADS (Thyroid Imaging Reporting and Data System) that evaluates each nodule based on its echogenicity (how it appears on ultrasound), shape, margins, internal composition, and whether it contains microcalcifications. Each nodule gets a risk score from 1 to 5. The American Thyroid Association recommends combining this score with the nodule’s size to decide whether a fine-needle aspiration biopsy is warranted. A nodule scoring TIRADS 5 (highest suspicion) needs a biopsy at just 1 centimeter, while a TIRADS 3 nodule (lower suspicion) only requires biopsy if it reaches 2.5 centimeters or larger. TIRADS 4 falls in between, with a threshold of 1.5 centimeters.
Cancer Risk in Multinodular Goiters
There’s a longstanding belief that nodules within a multinodular goiter are less likely to be cancerous than solitary thyroid nodules. Recent evidence has challenged this assumption. A meta-analysis found that when researchers specifically looked at incidental (unsuspected) thyroid cancers, the risk was essentially equal between multinodular and solitary nodule patients.
One study of patients who underwent surgery for multinodular goiter found that nearly one-third had unsuspected thyroid cancer. That number is high partly because it reflects a surgical population, meaning these were patients who already had reasons for concern. Still, it underscores why each nodule in a multinodular goiter needs to be evaluated individually rather than dismissed simply because there are multiple nodules present.
Treatment Options
If your multinodular goiter is small, not causing symptoms, and your thyroid function is normal, observation is a reasonable approach. The American Thyroid Association recommends follow-up every 6 to 18 months initially, with careful thyroid palpation and TSH testing at least yearly. If nothing changes substantially over the first 3 to 5 years, the interval between checks can be gradually extended. An ultrasound is repeated when a nodule seems to have grown on palpation, and any enlarging nodule should be biopsied.
Surgery becomes the recommended treatment when the goiter causes compressive symptoms, grows large (generally over 80 grams), raises concern for cancer, or contains a large nonfunctioning nodule. It’s also preferred for women planning pregnancy within the next 4 to 6 months, since radioactive iodine therapy is contraindicated during pregnancy and breastfeeding. Patients who undergo surgery for compressive goiters typically experience significant relief. Research shows that patients with swallowing difficulty before surgery have measurably increased esophageal space within six months afterward.
Radioactive iodine therapy is an alternative for toxic multinodular goiters or for patients who aren’t good surgical candidates due to other health conditions or a previously operated neck. It works by shrinking the overactive thyroid tissue over weeks to months. The tradeoff is that it often leads to hypothyroidism eventually, requiring lifelong thyroid hormone replacement. It cannot be used if there’s a concern for thyroid cancer.
For nontoxic goiters that are mildly symptomatic, some patients are treated with thyroid hormone supplementation to try to slow growth, though this approach has limited effectiveness and isn’t universally recommended. The choice between watching, operating, or using radioactive iodine depends on the size of the goiter, whether it’s producing excess hormone, the biopsy results of suspicious nodules, and your own preferences and health status.